Gastrointestinal Drugs: Global Market Report, 2019 Featuring Takeda Pharmaceticals, Allergan, Novo Nordisk, AstraZeneca, and Johnson & Johnson - ResearchAndMarkets.com

Loading...
Loading...

The "Gastrointestinal Drugs Global Market Report 2019" report has been added to ResearchAndMarkets.com's offering.

Gastrointestinal Drugs Market Global Report 2019 provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs market.

Asia Pacific was the largest region in the global gastrointestinal drugs market, accounting for 40% of the market in 2018. North America was the second largest region accounting for 29% of the global gastrointestinal drugs market. Africa was the smallest region in the global gastrointestinal drugs market.

Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

Scope

Where is the largest and fastest growing market for the gastrointestinal drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Gastrointestinal Drugs market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size B covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, gastrointestinal drugs indicators comparison.

Companies Featured

  • Takeda Pharmaceticals
  • Allergan PLC
  • Novo Nordisk A/S
  • AstraZeneca PLC
  • Johnson & Johnson

Topics Covered

1. Executive Summary

2. Report Structure

3. Gastrointestinal Drugs Market Characteristics

4. Gastrointestinal Drugs Market Product Analysis

5. Gastrointestinal Drugs Market Supply Chain

6. Gastrointestinal Drugs Market Customer Information

7. Gastrointestinal Drugs Market Trends & Strategies

8. Gastrointestinal Drugs Market Size & Growth

9. Gastrointestinal Drugs Market Regional Analysis

10. Gastrointestinal Drugs Market Segmentation

Loading...
Loading...

11. Gastrointestinal Drugs Market Metrics

12. Asia-Pacific Gastrointestinal Drugs Market

13. Western Europe Gastrointestinal Drugs Market

14. Eastern Europe Gastrointestinal Drugs Market

15. North America Gastrointestinal Drugs Market

16. South America Gastrointestinal Drugs Market

17. Middle East Gastrointestinal Drugs Market

18. Africa Gastrointestinal Drugs Market

19. Gastrointestinal Drugs Market Competitive Landscape

20. Key Mergers & Acquisitions in the Gastrointestinal Drugs Market

21. Market Background: Pharmaceutical Drugs Market

For more information about this report visit https://www.researchandmarkets.com/research/qc7msg/gastrointestinal?w=4

Loading...
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...